LyGenesis and Imagine Pharma Announce Joint Research Collaboration to Develop Novel Cell Therapies for Patients with Type 1 Diabetes
Apr 11, 2023
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes PITTSBURGH, PA – LyGenesis, Inc., a clinical-stage biotechnology company developing allogenic cell therapies…
Read More